Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 5
2008 3
2009 5
2010 9
2011 8
2012 10
2013 9
2014 15
2015 14
2016 17
2017 15
2018 15
2019 18
2020 20
2021 30
2022 24
2023 21
2024 22
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

242 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M. Taki M, et al. Among authors: matsumura n. Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7. Clin Cancer Res. 2021. PMID: 33827891 Review.
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. Miyamoto T, et al. Among authors: matsumura n. Cancer Immunol Res. 2022 Jan;10(1):56-69. doi: 10.1158/2326-6066.CIR-21-0407. Epub 2021 Nov 19. Cancer Immunol Res. 2022. PMID: 34799346 Free PMC article.
HER2-targeted therapy is changing.
Matsumura N. Matsumura N. Int Cancer Conf J. 2024 Sep 28;13(4):325. doi: 10.1007/s13691-024-00730-1. eCollection 2024 Oct. Int Cancer Conf J. 2024. PMID: 39398909 No abstract available.
Who benefits from the abscopal effect?
Matsumura N. Matsumura N. Int Cancer Conf J. 2023 May 23;12(3):167. doi: 10.1007/s13691-023-00616-8. eCollection 2023 Jul. Int Cancer Conf J. 2023. PMID: 37251012 Free PMC article. No abstract available.
From case reports to precision medicine.
Matsumura N. Matsumura N. Int Cancer Conf J. 2024 Jun 12;13(3):183. doi: 10.1007/s13691-024-00690-6. eCollection 2024 Jul. Int Cancer Conf J. 2024. PMID: 38962054 Free PMC article. No abstract available.
A message from the new editor-in-chief.
Matsumura N. Matsumura N. Int Cancer Conf J. 2020 Mar 27;9(2):51. doi: 10.1007/s13691-020-00410-w. eCollection 2020 Apr. Int Cancer Conf J. 2020. PMID: 32257752 Free PMC article. No abstract available.
Increasing our knowledge of germline variants.
Matsumura N. Matsumura N. Int Cancer Conf J. 2022 Jan 20;11(1):1. doi: 10.1007/s13691-021-00529-4. eCollection 2022 Jan. Int Cancer Conf J. 2022. PMID: 35127312 Free PMC article. No abstract available.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of sacituzumab govitecan for breast cancer, fruquintinib for colorectal cancer, amivantamab for lung cancer, repotrectinib for lung cancer, tasurgratinib for biliary tract cancer, enfortumab vedotin plus pembrolizumab for urothelial cancer, and dabrafenib plus trametinib for glioma in Japan.
Matsumura N, Mandai M. Matsumura N, et al. Int J Clin Oncol. 2024 Dec;29(12):1775-1776. doi: 10.1007/s10147-024-02644-7. Int J Clin Oncol. 2024. PMID: 39400851 No abstract available.
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval selpercatinib for solid tumor with RET fusion, gumarontinib for non-small cell lung cancer with MET gene exon 14 skipping mutation, momelotinib for myelofibrosis, bexarotene for adult T-cell leukemia/lymphoma, valemetostat for peripheral T-cell lymphoma, and pirtobrutinib for mantle cell lymphoma in Japan.
Matsumura N, Mandai M. Matsumura N, et al. Int J Clin Oncol. 2024 Sep;29(9):1207-1208. doi: 10.1007/s10147-024-02579-z. Int J Clin Oncol. 2024. PMID: 39007945 No abstract available.
242 results